Clinical Trial Update: The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating short-course ceftriaxone therapy for severe non-typhoidal Salmonella enterocolitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-typhoidal Salmonella Enterocolitis

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Diarrhea | Phase 4 | Status: UNKNOWN